Chemotherapy of respiratory viruses: prospects and challenges
- 1 August 1999
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 2 (4) , 244-258
- https://doi.org/10.1054/drup.1999.0091
Abstract
No abstract availableKeywords
This publication has 232 references indexed in Scilit:
- Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failureThe Journal of Pediatrics, 1996
- Cost of ribavirin therapy for respiratory syncytial virus infectionThe Journal of Pediatrics, 1995
- High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infectionThe Journal of Pediatrics, 1994
- Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: A double-blind, multicenter, placebo-controlled trialThe Journal of Pediatrics, 1994
- An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccinesVirus Research, 1994
- Respiratory syncytial virus puzzle: Clinical features, pathophysiology, treatment, and preventionThe Journal of Pediatrics, 1992
- Binding of an antiviral agent to a sensitive and a resistant human rhinovirus. Computer simulation studies with sampling of amino acid side-chain conformationsJournal of Molecular Biology, 1992
- High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infectionThe Journal of Pediatrics, 1990
- Three-dimensional structures of drug-resistant mutants of human rhinovirus 14Journal of Molecular Biology, 1989
- The broad spectrum antiviral agent ribavirin inhibits capping of mRNABiochemical and Biophysical Research Communications, 1979